Effect of frusemide on bodyweight loss and recovery in racing Standardbreds.

The research article discusses a study aimed to investigate the impact of the medication frusemide on bodyweight loss and recovery in Standardbred race horses. The study found that frusemide increased weight loss post-race as compared to the control group, but it did not affect short-term bodyweight recovery.

Design of the Study

• The study involved thirty Standardbred horses from seven different training stables.
• Races took place at the Red Mile in Lexington, Kentucky during the 2001 spring meeting.
• Horses were divided into two groups: those who received frusemide (14 horses, referred to as FRU) and those who did not (16 horses, known as NFRU).
• The doses of frusemide given to the FRU horses were 250 mg per horse, administered 4 hours prior to racing.

Observations and Measurements

• Horses were weighed at several time points: on the morning of race day, before warming up, after the race, and the following day.
• Bodyweight changes were calculated using the initial bodyweight as a reference.
• Prior to warm-up, the FRU horses exhibited a mean bodyweight reduction of 1.30%, while the NFRU horses showed a slight increase (roughly 0.19%).
• After the race, the FRU group experienced more bodyweight loss (3.55%) than the NFRU group (2.71%).
• The morning after the race, both the FRU and NFRU horses still weighed less than their initial bodyweights (by 0.90% and 1.24% respectively).

Conclusions drawn from the Study

• The administration of frusemide increased post-race weight loss among racing Standardbred horses compared to those that did not receive the drug.
• However, the use of frusemide did not influence short-term bodyweight recovery.
• The study suggests more research is needed to develop proper management strategies to replenish fluids and electrolytes in horses safely after strenuous exercise.